The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Pheochromocytoma: State-of-the-Art and Future Prospects
Abstract
This review provides current understanding of the pathophysiology of pheochromocytoma and the wide range of associated clinical manifestations that have led to earlier recognition of the disease. In addition, it reviews optimal screening methods and localization techniques that have enhanced the clinician’s ability to make the diagnosis with greater certainty. This article will also discuss alternative antihypertensive regimens and innovative anesthetic and surgical procedures that have made successful management more promising than ever before. Areas requiring further development include additional clinical experience with the measurement of plasma metanephrines that have been shown to have high sensitivity and specificity in the diagnosis of sporadic and familial pheochromocytoma, optimizing cost effectiveness of diagnostic imaging, improving the ability to predict and treat malignant pheochromocytoma, and elucidating not only the surgical approach but, perhaps with rapid advances in molecular genetics, ways of preventing familial pheochromocytoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
Peuler, J. D., & Johnson, G. A. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90070-4 · Cited by 1,899
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
The applications of PET in clinical oncology.
Strauss, L. G., & Conti, P. S. (1991) · PubMed · Cited by 844
Scintigraphic Localization of Pheochromocytoma
Sisson, J. C., Frager, M. S., Valk, T. W., Gross, M. D., Swanson, D. P., Wieland, D. M., Tobes, M. C., Beierwaltes, W. H., & Thompson, N. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050103 · Cited by 544
LUNDBERG, J. M., & TATEMOTO, K. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07157.x · Cited by 532
Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<417::aid-humu8>3.0.co;2-k · Cited by 479
Pheochromocytoma: Diagnosis, Localization and Management
Bravo, E. L., & Gifford, R. W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112007 · Cited by 471
Self-citationGoldstein, D. S., Feuerstein, G., Izzo, J. L., Kopin, I. J., & Keiser, H. R. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90139-9 · Cited by 467
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 465
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.
Sutton, M. G. S. J., Sheps, S. G., & Lie, J. T. (1981) · PubMed · Cited by 453
Extra-Adrenal Pheochromocytoma
Whalen, R. K., Althausen, A. F., & Daniels, G. H. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37119-7 · Cited by 452
Cloned human neuropeptide Y receptor couples to two different second messenger systems.
Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J., & Selbie, L. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5794 · Cited by 434
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Occurrence of Pheochromocytoma in Rochester, Minnesota, 1950 Through 1979
Beard, A. M., Sheps, S. G., Kurland, L. T., Carney, J. A., & Lie, J. T. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18873-3 · Cited by 402
Evolving Concepts in the Pathophysiology, Diagnosis, and Treatment of Pheochromocytoma
BRAVO, E. L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-356 · Cited by 393
Self-citationVON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Bravo, E. L., Tarazi, R. C., Gifford, R. W., & Stewart, B. H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909273011302 · Cited by 361
Self-citationEisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 349
The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
Eng, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351307 · Cited by 328
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 305
Current Management of Pheochromocytoma
REMINE, W. H., CHONC, G. C., VAN HEERDEN, J. A., SHEPS, S. G., & HARRISON, E. G. (1974) · Annals of Surgery · doi:10.1097/00000658-197405000-00029 · Cited by 299
de Leon, M. P. (1994) · Recent Results in Cancer Research · doi:10.1007/978-3-642-85076-9_7 · Cited by 260
Clonidine-Suppression Test: A Useful Aid in the Diagnosis of Pheochromocytoma
Bravo, E. L., Tarazi, R. C., Fouad, F. M., Vidt, D. G., & Gifford, R. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051107 · Cited by 250
Self-citationGermline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
Plasma Metanephrines in the Diagnosis of Pheochromocytoma
Lenders, J. W. M., Keiser, H. R., Goldstein, D. S., Willemsen, J. J., Friberg, P., Jacobs, M.-C., Kloppenborg, P. W. C., Thien, T., & Eisenhofer, G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00004 · Cited by 244
Prevalence of Clinically Unsuspected Pheochromocytoma. Review of a 50-Year Autopsy Series
Sutton, M. G. S. J., Sheps, S. G., & Lie, J. T. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)53807-0 · Cited by 237
Sasaki, M., Naomi, S., & Iwaoka, T. (1997) · PubMed · Cited by 229
O'Connor, D. T., & Bernstein, K. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409203111204 · Cited by 228
Pheochromocytoma: New concepts and future trends
Bravo, E. L. (1991) · Kidney International · doi:10.1038/ki.1991.244 · Cited by 222
Self-citationDetermination of metanephrines in plasma by liquid chromatography with electrochemical detection
Lenders, J. W., Eisenhofer, G., Armando, I., Keiser, H. R., Goldstein, D. S., & Kopin, I. J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.1.97 · Cited by 220
Management of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes
Lairmore, T. C., Ball, D. W., Baylin, S. B., & Wells, S. A. (1993) · Annals of Surgery · doi:10.1097/00000658-199306000-00001 · Cited by 218
Pacak, K., Eisenhofer, G., Carrasquillo, J. A., Chen, C. C., Li, S.-T., & Goldstein, D. S. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.6 · Cited by 216
O'Connor, D. T., & Frigon, R. P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43286-8 · Cited by 213
Pheochromocytoma in Sweden 1958–1981: An Analysis of the National Cancer Registry Data
STENSTRÖM, G., & SVÅRDSUDD, K. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02755.x · Cited by 213
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Stenström, G., & Svardsudd, K. F. (1986) · PubMed · Cited by 212
Turnover and Metabolism of Catecholamines in Patients with Pheochromocytoma*
Crout, J. R., & Sjoerdsma, A. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104898 · Cited by 200
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland
McNeil, A. R., Blok, B. H., Koelmeyer, T. D., Burke, M. P., & Hilton, J. M. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04358.x · Cited by 195
Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma
Lee, J. E., Curley, S. A., Gagel, R. F., Evans, D. B., & Hickey, R. C. (1996) · Surgery · doi:10.1016/s0039-6060(96)80056-0 · Cited by 184
Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma
Raber, W., Raffesberg, W., Bischof, M., Scheuba, C., Niederle, B., Gasic, S., Waldhäusl, W., & Roden, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2957 · Cited by 182
Preoperative and operative management of patients with phaeochromocytoma.
Ross, E. J., Prichard, B. N., Kaufman, L., Robertson, A. I., & Harries, B. J. (1967) · BMJ · doi:10.1136/bmj.1.5534.191 · Cited by 173
Urinary excretion of catecholamines and their metabolites in pheochromocytoma
Crout, J. R., Pisano, J. J., & Sjoerdsma, A. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90609-3 · Cited by 171
Langer, S. Z., Cavero, I., & Massingham, R. (1980) · Hypertension · doi:10.1161/01.hyp.2.4.372 · Cited by 166
SUCCESSFUL OUTCOMES IN PHEOCHROMOCYTOMA SURGERY IN THE MODERN ERA
ULCHAKER, J. C., GOLDFARB, D. A., BRAVO, E. L., & NOVICK, A. C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61762-2 · Cited by 162
Self-citationPET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.
Shulkin, B. L., Wieland, D. M., Schwaiger, M., et al. (1992) · PubMed · Cited by 153
Lundberg, J. M., Hökfelt, T. G. M., Hemsén, A., Theodorsson, E., Pernow, J., Hamberger, B., & Goldstein, M. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90224-7 · Cited by 138
Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
Floras, J. S., & Hara, K. (1993) · Journal of Hypertension · doi:10.1097/00004872-199306000-00009 · Cited by 137
Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma
Sprung, J., O’Hara, J. F., Gill, I. S., Abdelmalak, B., Sarnaik, A., & Bravo, E. L. (2000) · Urology · doi:10.1016/s0090-4295(99)00466-5 · Cited by 135
Self-citationGrassi, G. M., Bolla, G., Seravalle, G., Turri, C., Lanfranchi, A. K., & Mancia, G. (1997) · Clinical Science · doi:10.1042/cs0920285 · Cited by 134
Perioperative management of 63 patients with pheochromocytoma
Boutros, A. R., Bravo, E. L., Zanettin, G., & Straffon, R. A. (1990) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.57.7.613 · Cited by 133
Self-citationProye, C. A. G., Thévenin, D., Cécat, P., Petillot, P., Carnaille, B. M. L., Verin, P., Sautier, M., & Racadot-Leroy, N. (1989) · PubMed · Cited by 129
Glucagon Provocative Test for Pheochromocytoma
Lawrence, A. M. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-6-1091 · Cited by 129
Pheochromocytoma with predominant epinephrine secretion
Page, L. B., Raker, J. W., & Berberich, F. R. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90195-8 · Cited by 128
Benn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206300 · Cited by 108
Neumann, H. P. H. (1995) · JAMA · doi:10.1001/jama.1995.03530140061033 · Cited by 107
Hoff, A. O., Cote, G. J., & Gagel, R. F. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.377 · Cited by 102
Corder, R., Emson, P. C., & Lowry, P. J. (1984) · Biochemical Journal · doi:10.1042/bj2190699 · Cited by 95
Pheochromocytoma in Von Hippel-Lindau Disease
Hes, F. J., Höppener, J. W. M., & Lips, C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021466 · Cited by 90
Nakamura, K., Yamaki, M., Sarada, M., Nakayama, S., Vibat, C. R. T., Gennis, R. B., Nakayashiki, T., Inokuchi, H., Kojima, S., & Kita, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.521 · Cited by 90
Radiofrequency Ablation: a Novel Approach for Treatment of Metastatic Pheochromocytoma
Pacák, K., Fojo, T., Goldstein, D. S., Eisenhofer, G., Walther, M. M., Linehan, W. M., Bachenheimer, L. C., Abraham, J., & Wood, B. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.648 · Cited by 85
Clinically Unsuspected Pheochromocytomas
Krane, N. K. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130064008 · Cited by 79
Quality of life after bilateral adrenalectomy in MEN 2.
Telenius-Berg, M., Ponder, M. A., Berg, B., et al. (1989) · PubMed · Cited by 72
Shapiro, B., Sisson, J. C., Wieland, D. M., Mangner, T. J., Zempel, S., Mudgett, E. E., Gross, M. D., Carey, J. E., Zasadny, K. R., & Beierwaltes, W. H. (1991) · PubMed · Cited by 71
The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma
Nativ, O., Grant, C. S., Sheps, S. G., O'Fallon, J. R., Farrow, G. M., van Heerden, J. A., & Lieber, M. M. (1992) · Cancer · doi:10.1002/1097-0142(19920601)69:11<2683::aid-cncr2820691110>3.0.co;2-m · Cited by 70
Kudva, Y. C., Young, W. F., Thompson, G. B., Grant, C. S., & van Heerden, J. A. (1999) · The Endocrinologist · doi:10.1097/00019616-199903000-00002 · Cited by 70
Plouin, P., Patrice Degoulet, A., Tugayé, A., et al. (1981) · PubMed · Cited by 68
Biochemical Diagnosis of Pheochromocytoma—Is it Time to Switch to Plasma-Free Metanephrines?
Eisenhofer, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021913 · Cited by 63
Tsujimoto, G., Honda, K., Hoffman, B. B., & Hashimoto, K. (1987) · Circulation Research · doi:10.1161/01.res.61.1.86 · Cited by 62
Blood pressure regulation in pheochromocytoma
BRAVO, E. L., Tarazi, R. C., Fouad, F. M., Textor, S. C., Gifford, R. W., & Vidt, D. G. (1982) · Hypertension · doi:10.1161/01.hyp.4.3_pt_2.193 · Cited by 61
Self-citationPrimary Extra-Adrenal Pheochromocytoma Positive I-123 MIBG Imaging with Negative I-131 MIBG Imaging
Shulkin, B. L., Shapiro, B., Francis, I. R., Dorr, R. P., SHEN, S.-W., & Sisson, J. C. (1986) · Clinical Nuclear Medicine · doi:10.1097/00003072-198612000-00012 · Cited by 60
Adrenal Medullary Disease in Multiple Endocrine Neoplasia Type 2: Appropriate Management
Evans, D. B., Lee, J. E., Merrell, R. C., et al. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30123-3 · Cited by 55
Routine total bilateral adrenalectomy is not warranted in childhood familial pheochromocytoma
Albanese, C. T., & Wiener, E. S. (1993) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(05)80307-0 · Cited by 54
Canale, M. P., & Bravo, E. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175970 · Cited by 54
Self-citationInhibin/Activin B-Subunit Expression in Pheochromocytomas Favors Benign Diagnosis
Salmenkivi, K., Arola, J. T., Voutilainen, R., Ilvesmäki, V., Haglund, C., Kahri, A. I., Heikkilä, P., & Liu, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7446 · Cited by 52
A reevaluation of the hemodynamics of pheochromocytoma.
Bravo, E., Fouad-Tarazi, F. M., Rossi, G. P., Imamura, M., Lin, W. W., Madkour, M. A., Wicker, P., Cressman, M. D., & Saragoça, M. A. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i128 · Cited by 50
Self-citationProduction, characterization, and expression of neuropeptide Y by human pheochromocytoma.
Senanayake, P. D., Denker, J., Bravo, E. L., & Graham, R. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118310 · Cited by 48
Self-citationBravo, E. L. (2002) · Cardiology in Review · doi:10.1097/00045415-200201000-00009 · Cited by 48
Self-citationPlasma metanephrines: a novel and cost-effective test for pheochromocytoma
Eisenhofer, G., Walther, M. M., Keiser, H. R., Lenders, J. W. M., Friberg, P., & Pacák, K. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000001000005 · Cited by 44
The Anesthetic Management of Pheochromocytoma: Effect of Preoperative Adrenergic Blocking Drugs
Perry, L. B., & Gould, A. B. (1972) · Anesthesia & Analgesia · doi:10.1213/00000539-197201000-00010 · Cited by 41
Silent Adrenal Nodules in von Hippel-Lindau Disease Suggest Pheochromocytoma
Aprill, B. S., Drake, A. J., Lasseter, D. H., & Shakir, K. M. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-6-199403150-00006 · Cited by 40
The anesthetic management of pheochromocytoma effect of preoperative adrenergic blocking drugss.
Perry, L. B., & Gould, A. B. (1972) · PubMed · Cited by 38
Sympathetic Nerve Traffic Responses to Surgical Removal of Pheochromocytoma
Grassi, G. M., Seravalle, G., Turri, C., & Mancia, G. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.461 · Cited by 34
Neumann, D. R., Basile, K. E., Bravo, E. L., et al. (1996) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199603000-00028 · Cited by 27
Self-citationEffect of Buspirone on Urinary Catecholamine Assays
Cook, F. J., Chandler, D. W., & Snyder, D. K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502093320617 · Cited by 27
Tsuchimochi, S., Nakajo, M., Nakabeppu, Y., et al. (1997) · Clinical Nuclear Medicine · doi:10.1097/00003072-199710000-00005 · Cited by 21
Cited by
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A.-P., Grossman, A. B., Kimura, N., Mannelli, M., McNicol, A. M., & Tischler, A. S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0396 · Cited by 680
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Preoperative Management of the Pheochromocytoma Patient
Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1720 · Cited by 576
Metadata
- Authors
- Bravo, E. L., & Tagle, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 539-553
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1966018543
- Cited by
- 493
- References
- 89
- FWCI
- 23.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.